Cytoskeletal messenger RNA stability in human neocortex: studies in normal aging and in Alzheimer's disease.
Lukiw WJ, Wong L, McLachlan DR
Purpose
The purpose of this paper was to investigate the effect of post-mortem interval (PMI) and Alzheimer's disease on transcript abundance in the neocortex.
Conclusion
Postmortem degradation rates of the cytoskeletal mRNAs occurred in a transcript dependent manner. HNF-L, GFAP and alpha tubulin remained relatively stable until 4.5 h postmortem, but then declined rapidly between 4.5 and 6.5 h postmortem reaching 51%, 74%, and 78% of 0.7 h postmortem levels respectively. HNF-L, GFAP and alpha tubulin degradation continued at a slower rate after 6.5 h post-mortem declining to 36%, 60% and 72% of 0.7 h postmortem levels by 13.5 h postmortem respectively. In contrast, degradation of beta actin was robust and quick, with transcript levels 69% of 0.7 h postmortem values by 4.5 h and 34% by 13.5 h postmortem. The authors postulate that postmortem RNA stability and transcript size may be loosely correlated. Alzheimer's disease decreased the 4300 bp, but not 2600 bp HNF-L transcript abundance, but not postmortem stability. No effect of Alzheimer's disease on postmortem transcript stability was noted, but only HNF-L was directly compared.
Studies (2)
Purpose
The purpose of this study was to determine the effect of Alzheimer's disease on select transcripts.
Summary of Findings
No change in PrP27-30, 18S ribosomal RNA or the 2600 bp transcript of H1 internucleosomal marker (HNF-L) were observed by northern blot in Alzheimer's disease. A specific reduction in the 4300 bp transcript of HNF-L was associated with Alzheimer's disease. The authors conclude that while no general effect of Alzheimer's disease on transcript abundance in the neocortex was observed there is a specific decline in the 4300 bp transcript of HNF-L.
Biospecimens
TissueBrainPreservation Types
FrozenDiagnoses
Alzheimer's DiseaseAutopsyNormalMultiple SclerosisPlatforms
RNADot blot or slot blotRNANorthern blotPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Alzheimer's diseaseNot Alzheimer's diseaseNorthern blot Specific Targeted nucleic acid 18S ribosomal RNAHuman neurofilament light chain (HNF-L)Prion protein coding for the 27-30 kDa infectious particle (PrP27-30)
Purpose
The purpose of this study was to compare the effect of PMI on the decay of cytoskeletal specific RNAs in the neocortex by northern blot analysis.
Summary of Findings
Postmortem degradation rates of the cytoskeletal mRNAs occurred in a transcript dependent manner. HNF-L, GFAP and alpha tubulin remained relatively stable until 4.5 h postmortem (86%, 87% and 92% of 0.7 h postmortem values respectively). The biggest decrease in stability for HNF-L, GFAP and alpha tubulin occurred between 4.5-6.5 h postmortem bringing levels down to 51%, 74%, and 78% of 0.7 h postmortem levels respectively. HNF-L, GFAP and alpha tubulin degradation continued reaching 36%, 60% and 72% of 0.7 h postmortem levels by 13.5 h postmortem respectively. In contrast, beta actin displayed the greatest magnitude of effect, degrading to 69% of 0.7 h postmortem values by 4.5 h and reaching 34% of 0.7 h postmortem values by 13.5 h postmortem. The authors postulate that postmortem RNA stability and size correlate loosely with long transcripts like HNF-L (4300 bp) being more stable than short transcripts such as beta actin (2000 bp). No effect of Alzheimer's disease on postmortem transcript stability was noted, but only HNF-L was compared directly. The authors conclude that PMI differentially affects the stability of RNA transcripts and that Alzheimer's disease does not have an overall affect on HNF-L postmortem transcript stability.
Biospecimens
TissueBrainPreservation Types
FrozenDiagnoses
Multiple SclerosisPneumonia/Respiratory InfectionCardiovascular DiseaseNeoplasticCarcinomaAutopsyOther diagnosesPlatforms
RNANorthern blotPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Alzheimer's diseaseNot Alzheimer's diseasePreaquisition Postmortem interval 0.7 h11.0 h12.0 h13.5 h3.5 h4.0 h4.5 h6.5 hNorthern blot Specific Targeted nucleic acid Alpha tubulinBeta actinGlial fibrillary acidic protein (GFAP)Human neurofilament light chain (HNF-L)